MOZ, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.477
AS - Asia 953
EU - Europa 828
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 6
OC - Oceania 3
SA - Sud America 3
Totale 7.286
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.467
CN - Cina 529
SG - Singapore 270
IT - Italia 234
FI - Finlandia 157
SE - Svezia 136
VN - Vietnam 79
DE - Germania 74
FR - Francia 65
GB - Regno Unito 63
UA - Ucraina 34
HK - Hong Kong 22
IN - India 22
EU - Europa 15
RU - Federazione Russa 15
KR - Corea 14
NL - Olanda 12
CA - Canada 9
ES - Italia 8
GR - Grecia 8
ID - Indonesia 7
IE - Irlanda 7
RO - Romania 6
EG - Egitto 5
PL - Polonia 4
AU - Australia 3
IQ - Iraq 3
JP - Giappone 3
AT - Austria 2
BE - Belgio 2
CL - Cile 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
AR - Argentina 1
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
IL - Israele 1
IR - Iran 1
MX - Messico 1
ZA - Sudafrica 1
Totale 7.286
Salva come PNG Salva come JPEG
Città #
Fairfield 649
Woodbridge 611
Ann Arbor 570
Houston 536
Chandler 523
Ashburn 369
Cambridge 252
Wilmington 227
Seattle 220
Singapore 212
Boardman 152
Jacksonville 136
Princeton 114
Des Moines 111
Medford 101
Beijing 92
Dong Ket 79
Santa Clara 78
Padova 72
Nanjing 68
Helsinki 67
San Diego 54
Roxbury 53
Shenyang 29
Jinan 28
Hebei 25
Hong Kong 21
Nanchang 21
Guangzhou 20
Changsha 19
Los Angeles 18
Tianjin 15
Jiaxing 14
New York 14
Zhengzhou 14
Shanghai 13
Munich 12
Nowon-gu 12
London 11
Kunming 10
Milan 10
Redwood City 10
Taizhou 10
Pune 9
Casier 8
Hefei 8
Lanzhou 8
Dallas 7
Dublin 7
Fisciano 7
Haikou 7
Washington 7
Cagliari 6
Indiana 6
Indianapolis 6
Ningbo 6
Cairo 5
Florence 5
Frankfurt am Main 5
Hangzhou 5
Limena 5
Norwalk 5
Bologna 4
Borås 4
Fuzhou 4
Kilburn 4
Krakow 4
Lappeenranta 4
Mahon 4
Mestre 4
Montreal 4
New Delhi 4
Ogden 4
Paris 4
Phoenix 4
Rome 4
Chengdu 3
Dearborn 3
Detroit 3
Harringay 3
Kharkiv 3
Madrid 3
Malo 3
Mestrino 3
Rockville 3
Taiyuan 3
Tappahannock 3
Tortoreto 3
Verona 3
Wuhan 3
Yellow Springs 3
Adelfia 2
Aprilia 2
Baotou 2
Chicago 2
Chiyoda-ku 2
Dresden 2
Fremont 2
Genoa 2
Groningen 2
Totale 5.913
Salva come PNG Salva come JPEG
Nome #
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 164
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 162
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 145
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 142
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 140
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 129
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 128
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors 127
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 125
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 119
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 118
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 111
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 107
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 106
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 101
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study 101
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 98
Convergence and cooperativity between EGFR, TGFB, insulin and S100A8/A9 signaling in PDAC 95
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 91
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 90
Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFa therapy 90
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 87
VITAMIN D:FOE OF THE IMMUNE RESPONSE IN PANCREATIC CANCER 87
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 86
Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling 86
Emerging role of monocytes and of their intracellular calcium content in spondyloarthritis 86
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 85
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 85
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 79
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 78
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 76
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 76
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 76
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 75
Convergence and cooperativity between EGFR, TGFb, insulin and S100A8/A9 signaling in pancreatic ductal adenocarcinoma (PDAC) 75
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 75
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 74
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 73
Maldi-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and Complement C3. 73
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 73
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 72
NT-S100A8 effects on cell signalling. 72
Epidermal growth factor (EGF) chronic stimulation causes Smad4-dependent signaling bypass in PDAC 71
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 70
Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer. 70
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 69
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 69
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 68
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 68
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 66
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 64
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 64
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 64
Epidermal growth factor (EGF) chronic stimulation causes Smad4- dependent signaling bypass in pancreatic ductal adenocarcinoma (PDAC) 63
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 63
Vitamin D prevents pancreatic cancer-induced apoptosis signaling of inflammatory cells 62
Discovery of new serum biomarkers for pancreatic cancer diagnosis by Maldi-Tof analysis. 61
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 60
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 60
Analogs of vitamin e epitomized by α-tocopheryl succinate for pancreatic cancer treatment: In vitro results induce caution for in vivo applications 60
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 57
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 57
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 56
The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells 55
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 55
Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study 55
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 54
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 54
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 54
Emerging role of monocytes and their intracellular calcium pattern in spondyloarthritis 54
S100A8 and S100A9 target AKT, mTOR and NF-KB signalling in pancreatic cancer cells. 53
PRE-ANALYTICAL EFFECTS ON ESTABLISHED AND EMERGING BIOMARKERS OF CARDIOVASCULAR DISEASE (CVD) 52
Genome-wide association study identifies an early onset pancreatic cancer risk locus 51
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 50
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 50
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 50
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 49
Hyperglycemia-Induced S100A8 and S100A9 Target Akt and NF-kB Signalling in Pancreatic Cancer Cells. 49
Effectiveness of the combined evaluation of KLK3 genetics and f/tPSA ratio for prostate cancer diagnosis 49
The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave 49
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 48
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 47
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 47
PANCREATIC CANCER (PaCa)-DERIVED SOLUBLE MEDIATORS INDUCE DENDRITIC CELLS (DC) TO ACQUIRE AN IMMUNESUPPRESSIVE PHENOTYPE BY DOWNREGULATING CTLA4 47
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 46
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 45
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 44
Hyperglycemia-induced S100A8 and S100A9 target Akt and NF-kB signaling in pancreatic cancer cells. 43
Blood expression of matrix metallo-proteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 41
Hypergycemia-induced S100A8 and S100A9 expression target AKT, and NF-KB signalling in pancreatic cancer cells. 40
Clinical Relevance of Circulating and Splenic Immature Myeloid Cells in Pancreatic Diseases. 39
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 39
Aeskulisa and H-TTG/DGP scren for celiac disease diagnosis 38
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 37
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 37
The Inflammatory Calcium Binding Protein S100A8 and Its N-Terminal Proteolytic Fragment Interact with Transforming Growth Factor-Beta1 (TGF-b1) and Alter Akt, mTOR and NF-kappa B Cancer Cell Signalling. 36
SMAD4 RELATED TRANSFER THROUGH EXOSOMES OF GLYCOLYTIC ENZYMES AND miR-1260 UNDERLIES THE REVERSE WARBURG EFFECT IN PDAC 35
SMAD4 Deletion and EGF Co-Operate in Favoring mTOR Activation in PDAC Cells 32
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus. 31
SMAD4 LOSS ENABLES EGF, TGFB1 AND S100A8/ A9 INDUCED ACTIVATION OF CRITICAL PATHWAYS TO PANCREATIC CANCER INVASION 31
Totale 7.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.922
article - articoli 13.389
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.311
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020818 0 0 0 0 106 83 94 112 113 190 76 44
2020/2021965 33 52 83 120 53 51 31 54 108 144 102 134
2021/2022998 14 173 68 56 36 77 28 98 55 11 94 288
2022/20231.116 203 107 13 129 194 159 10 76 148 9 38 30
2023/2024649 21 70 66 50 47 64 64 77 21 50 51 68
2024/2025662 15 133 131 124 259 0 0 0 0 0 0 0
Totale 7.354